Issue 43, 2019

Enzyme-mediated dual-targeted-assembly realizes a synergistic anticancer effect

Abstract

We designed and synthesized homochiral-peptide-based boron diketonate complexes. Co-administration of the two stereoisomers in cancer cells led to molecular assembly targeting both the plasma membrane and the lysosomes mediated via membrane-bonded enzymes. The dual-targeted-assembly generates a synergistic anticancer effect with amplified cancer spheroid toxicity and enhanced inhibition efficacy on cancer cell migration.

Graphical abstract: Enzyme-mediated dual-targeted-assembly realizes a synergistic anticancer effect

Associated articles

Supplementary files

Article information

Article type
Communication
Submitted
08 Apr 2019
Accepted
01 May 2019
First published
09 May 2019

Chem. Commun., 2019,55, 6126-6129

Enzyme-mediated dual-targeted-assembly realizes a synergistic anticancer effect

D. Mang, S. Zhang, X. Wu, X. Hu, T. Mochizuki, G. Li and Y. Zhang, Chem. Commun., 2019, 55, 6126 DOI: 10.1039/C9CC02715G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements